Jane Street
EWTX icon

Jane Street’s Edgewise Therapeutics EWTX Stock Holding History

Jane Street’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$432K Sell
13,700
-17,600
-56% -$508K ﹤0.01% 8397
2025
Q4 		$777K Buy
+31,300
New +$628K ﹤0.01% 6697
2025
Q2 		– Sell
-151,600
Closed -$3.34M – 9962
2025
Q1 		$3.34M Buy
151,600
+71,300
+89% +$1.87M ﹤0.01% 3562
2024
Q4 		$2.14M Sell
80,300
-299,300
-79% -$9.53M ﹤0.01% 3988
2024
Q3 		$10.1M Buy
+379,600
New +$7.55M ﹤0.01% 1905

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jane Street's EWTX Position: Q1 2026 in Review

Jane Street opened a new position in Edgewise Therapeutics (EWTX) in Q1 2026: 35,578 shares worth $1.12M. The stake represents ﹤0.01% of the portfolio and ranks #6254 among its holdings. This is a return to the name: Jane Street previously reported a position in EWTX as recently as Q3 2025.

Jane Street first reported a position in EWTX in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.34M in Q3 2024. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Jane Street held 35,578 shares of Edgewise Therapeutics worth $1.12M as of Q1 2026.
  • Edgewise Therapeutics was a new Jane Street position in Q1 2026.
  • Edgewise Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6254 holding.
  • Jane Street first reported a position in Edgewise Therapeutics in Q2 2022 and has held it in 14 quarters since.
  • Jane Street's Edgewise Therapeutics position peaked at $1.34M in Q3 2024.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.